Key details
Sponsor
CuraSen Therapeutics, Inc.
Enrollment target
~12 participants
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated February 2026